- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07768995
The Effect of a Psychiatric Nursing Approach Based on the Tidal Model on Psychological Resilience and Self-Compassion Levels in Patients Diagnosed With Anxiety Disorder
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study aims to evaluate the effectiveness of a Tidal Model-based psychiatric nursing intervention in clinical practice and to emphasize the importance of holistic, patient-centered approaches in nursing care for patients with anxiety disorders.
Study Hypotheses:
Hypothesis 1 (H1): The psychological resilience levels of individuals who receive the Tidal Model-based psychiatric nursing approach are statistically significantly higher after the intervention compared to the individuals in the control group.
Hypothesis 2 (H2): The self-compassion levels of individuals who receive the Tidal Model-based psychiatric nursing approach are statistically significantly higher after the intervention compared to the individuals in the control group.
Hypothesis 3 (H3): The psychological resilience levels of individuals in the intervention group show a statistically significant increase after the intervention compared to before the intervention.
Hypothesis 4 (H4): The self-compassion levels of individuals in the intervention group show a statistically significant increase after the intervention compared to before the intervention.
Null Hypothesis (H0): There is no statistically significant difference between the intervention and control groups in terms of psychological resilience and self-compassion levels after the intervention.
Anxiety Disorder, Online Care, Tidal Model, Self-Compassion, Psychological Resilience, Psychiatric Nursing
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Ankara
-
Ankara, Ankara, Turchia (Türkiye), 06010
- University of Health Sciences, Gulhane Institute of Health Sciences
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Being officially diagnosed with Anxiety Disorder according to DSM-5 diagnostic criteria,
- Being between 18-65 years of age,
- Having access to a smartphone, computer, and internet connection sufficient to participate in online sessions,
- Volunteering to participate in the study and signing the Informed Consent Form.
Exclusion Criteria:
- Having acute psychosis, bipolar disorder, dementia, or a severe neurological disease in addition to anxiety disorder,
- Having cognitive or sensory loss that prevents communication, vision, or hearing,
- Currently participating in another active psychotherapy or psychosocial intervention program simultaneously.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Intervention Group
Participants in this group receive one-on-one online psychiatric nursing interventions based on the Tidal Model, conducted via remote video conferencing.
The sessions aim to enable patients to recognize their inner strengths and to increase their psychological resilience and self-compassion levels.
|
One-on-one nursing sessions were conducted via online video conferencing platforms based on the philosophy of the Tidal Model.
The intervention involves session processes aligned with the model's domains (Self, World, Partnership) and its ten commitments, enabling patients to construct their own stories, develop anxiety coping skills (psychological resilience), and cultivate a supportive inner voice (self-compassion).
|
|
Nessun intervento: Control Group
Participants in this group did not receive any additional psychosocial or nursing interventions between the dates of completing the pre-test and post-test forms.
They completed the process continuing only with their routine clinical psychiatric follow-ups and medical treatments at the healthcare institution where they were registered.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Psychological Resilience Scale Score
Lasso di tempo: Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Change in psychological resilience levels as measured by the Resilience Scale for Adults (33 items, 5-point Likert scale).
Minimum score is 33 and maximum score is 165.
Higher scores indicate higher levels of psychological resilience (better outcome).
Pre-test was administered at Week 0 before intervention, and post-test was administered at Week 8 immediately following the 8-week intervention.
|
Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Self-Compassion Scale Score
Lasso di tempo: Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Change in self-compassion levels as measured by the Turkish version of the Self-Compassion Scale (Deniz, Kesici, & Sumer, 2008; 24 items, 5-point Likert scale).
Minimum score is 24 and maximum score is 120.
Higher scores indicate higher levels of self-compassion (better outcome).
Pre-test was administered at Week 0 before intervention, and post-test was administered at Week 8 immediately following the 8-week intervention.
|
Baseline (Week 0, pre-test 1 day before intervention) and Post-test (Week 8, 1 day after completion of the 8-week intervention)
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 2025-462
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .